Business
GMT: Genomtec accelerates M&A, slashes production costs, and strengthens its position in diagnostics
GMT: Genomtec accelerates M&A, slashes production costs, and strengthens its position in diagnostics
About this update from Genomtec Sa
Genomtec is advancing its M&A process, achieving major cost reductions and technology improvements in genetic diagnostics. The company is progressing with funded projects and targets strategic partnerships, with its competitive, low-cost platform positioned for growth in the expanding diagnostics market.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.